Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Shankar

Showing results (161-170 of 238) with videos related to

Pageof 24
Sort By:
The Journal of Infection|January 11, 2025
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trialVisa Nurmi, Richard Mayne, Chanice Knight, et al.
Trials|May 13, 2022
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Thorax|March 12, 2024
Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypesDavid Benjamin Antcliffe, Yuxin Mi, Shalini Santhakumaran, et al.
Intensive Care Medicine|October 21, 2024
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsisJ Kenneth Baillie, Derek Angus, Katie Burnham, et al.
Nature Medicine|January 22, 2022
A guide to immunotherapy for COVID-19Frank L van de Veerdonk, Evangelos Giamarellos-Bourboulis, Peter Pickkers, et al.
NEJM Evidence|November 18, 2024
Blood Pressure Targets for Adults with Vasodilatory Shock - An Individual Patient Data Meta-AnalysisFederico Angriman, Neda Momenzade, Neill K J Adhikari, et al.
Eclinicalmedicine|November 8, 2021
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Journal of Critical Care|May 11, 2023
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational studyLuis Felipe Reyes, Esteban Garcia-Gallo, Srinivas Murthy, et al.
BMJ Open|January 4, 2023
Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis)Jonathan Scott, Loredana Trevi, Hannah McNeil, et al.
Intensive Care Medicine|June 20, 2018
Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT studyAndrew Conway Morris, Deepankar Datta, Manu Shankar-Hari, et al.
Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:
Pageof 24
The Journal of Infection|January 11, 2025
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trialVisa Nurmi, Richard Mayne, Chanice Knight, et al.
Trials|May 13, 2022
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Thorax|March 12, 2024
Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypesDavid Benjamin Antcliffe, Yuxin Mi, Shalini Santhakumaran, et al.
Intensive Care Medicine|October 21, 2024
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsisJ Kenneth Baillie, Derek Angus, Katie Burnham, et al.
Nature Medicine|January 22, 2022
A guide to immunotherapy for COVID-19Frank L van de Veerdonk, Evangelos Giamarellos-Bourboulis, Peter Pickkers, et al.
NEJM Evidence|November 18, 2024
Blood Pressure Targets for Adults with Vasodilatory Shock - An Individual Patient Data Meta-AnalysisFederico Angriman, Neda Momenzade, Neill K J Adhikari, et al.
Eclinicalmedicine|November 8, 2021
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Journal of Critical Care|May 11, 2023
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational studyLuis Felipe Reyes, Esteban Garcia-Gallo, Srinivas Murthy, et al.
BMJ Open|January 4, 2023
Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis)Jonathan Scott, Loredana Trevi, Hannah McNeil, et al.
Intensive Care Medicine|June 20, 2018
Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT studyAndrew Conway Morris, Deepankar Datta, Manu Shankar-Hari, et al.
Pageof 24